News
As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...
The Stephenson Global Pancreatic Cancer Research Institute and its partner City of Hope, one of the country’s largest and ...
14h
News-Medical.Net on MSNAI model accurately detects breast cancer on MRI scansAn AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed ...
Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to ...
BluSky AI, Inc. has announced a strategic partnership with Data Specialties Inc. (DSI) to act as its official provider of pre ...
1h
Zacks Investment Research on MSNHologic Rides on AI-Powered Breast Health Innovations: What's Next?Breast cancer continues to be a significant global health challenge and the leading cause of cancer-related deaths among women. Artificial Intelligence is playing an increasingly vital role in ...
11h
WATE 6 On Your Side on MSNUT research could help diagnose breast cancer more quickly by using AIUniversity of Tennessee researchers are using artificial intelligence to more quickly determine treatment plans for breast cancer patients.
WATE Knoxville on MSN16h
AI for breast cancer treatmentUniversity of Tennessee researchers are turning to artificial intelligence to come up with treatment plans for breast cancer patients more quickly.
11h
News Medical on MSNAI tool predicts tumor aggressiveness using protein markersAs cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.
UNSW Sydney scientists are working to develop Australia's first commercialised lipid-based blood test for breast cancer detection powered by ...
The system will then be able to compare it with cancer staging data to determine what stage of breast cancer a patient has.
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted cancer therapies using its proprietary RADR® AI platform to transform the cost, pace and precision of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results